A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity

Hippocampus

Volumn 27, Issue 9, 2017, Pages 985-998

  Hurst, Katrina ^a   Badgley, Corinne ^a   Ellsworth, Tanner ^a   Bell, Spencer ^a   Friend, Lindsey ^a   Prince, Brad ^a   Welch, Jacob ^a   Cowan, Zack ^a   Williamson, Ryan ^a   Lyon, Chris ^a   Anderson, Brandon ^a   Poole, Brian ^a   Christensen, Michael ^a   McNeil, Michael ^a   Call, Jarrod ^a   Edwards, Jeffrey G ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

anxiety; hippocampus; immobility; long term depression; long term potentiation; memory; orphan G protein coupled receptors

Indexed keywords

COMPLEMENTARY DNA; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 55; LYSOPHOSPHATIDYLINOSITOL RECEPTOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL; UNCLASSIFIED DRUG; 4-(4-(3-HYDROXYPHENYL)-3-(4-METHYLPHENYL)-6-OXO-1H,4H,5H,6H-PYRROLO(3,4-C)PYRAZOL-5-YL)BENZOIC ACID; AZABICYCLO DERIVATIVE; BENZOIC ACID DERIVATIVE; CANNABINOID RECEPTOR; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1; GLUTAMIC ACID; GPR55 PROTEIN, MOUSE; GREEN FLUORESCENT PROTEIN; LYSOPHOSPHATIDYLINOSITOL; LYSOPHOSPHOLIPID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; ELEVATED PLUS MAZE TEST; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPAL SLICE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LONG TERM POTENTIATION; MORRIS WATER MAZE TEST; NATIONAL HEALTH ORGANIZATION; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RADIAL ARM MAZE TEST; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CYTOLOGY; DRUG EFFECTS; ELECTROSTIMULATION; GENE EXPRESSION REGULATION; GENETICS; MALE; MAZE TEST; METABOLISM; MOUSE; NEWBORN; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; RECOGNITION; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; AZABICYCLO COMPOUNDS; BENZOATES; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; GENE EXPRESSION REGULATION; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; LYSOPHOSPHOLIPIDS; MALE; MAZE LEARNING; MICE; MICE, TRANSGENIC; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECOGNITION (PSYCHOLOGY);

EID: 85021354606     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.22747     Document Type: Article

References (57)

1. Anavi-Goffer, S., Baillie, G., Irving, A. J., Gertsch, J., Greig, I. R., Pertwee, R. G., & Ross, R. A. (2012). Modulation of L-alpha-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids. Journal of Biological Chemistry, 287(1), 91–104.
2. Andradas, C., Caffarel, M. M., Perez-Gomez, E., Salazar, M., Lorente, M., Velasco, G., … Sanchez, C. (2011). The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK. Oncogene, 30(2), 245–252.
3. Bennion, D., Jensen, T., Walther, C., Hamblin, J., Wallmann, A., Couch, J., … Beckstead, S. (2011). Transient receptor potential vanilloid 1 agonists modulate hippocampal CA1 LTP via the GABAergic system. Neuropharmacology, 61(4), 730–738.
4. Bliss, T. V. P., & Collingridge, G. L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature, 361(6407), 31–39.
5. Bliss, T. V. P., & Lomo, T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. Journal of Physiology, 232(2), 331–356.
6. Burgess, N., Maguire, E. A., & O'keefe, J. (2002). The Human Hippocampus and Spatial and Episodic Memory. Neuron, 35(4), 625–641.
7. Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012). Endocannabinoid Signaling and Synaptic Function. Neuron, 76(1), 70–81.
8. Chavez, A. E., Chiu, C. Q., & Castillo, P. E. (2010). TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nature Neuroscience, 13(12), 1511–1518.
9. Cherif, H., Argaw, A., Cecyre, B., Bouchard, A., Gagnon, J., Javadi, P., … Bouchard, J. F. (2015). Role of GPR55 during axon growth and target innervation(1,2,3). eNeuro, 2(5).
10. Chevaleyre, V., & Castillo, P. E. (2004). Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron, 43(6), 871–881.
11. Coria, S. M., Roura-Martinez, D., Ucha, M., Assis, M. A., Miguens, M., Garcia-Lecumberri, C., … Ambrosio, E. (2014). Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats. Progress in Neuropsychopharmacology and Biological Psychiatry, 53, 15–22.
12. Del Castillo, J., & Katz, B. (1954). Quantal components of the end-plate potential. Journal of Physiology, 124(3), 560–573.
13. Deliu, E., Sperow, M., Console-Bram, L., Carter, R. L., Tilley, D. G., Kalamarides, D. J., … Benamar, K. and others. (2015). The lysophosphatidylinositol receptor GPR55 modulates pain perception in the periaqueductal gray. Molecular Pharmacology, 88(2), 265–272.
14. Di Marzo, V., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., … Martin, B. R. (2000). Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice. Evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain. Journal of Neurochemistry, 75(6), 2434–2444.
15. Dudek, S. M., & Bear, M. F. (1992). Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-d-aspartate receptor blockade. Proceedings of the National Academy of Sciences, 89(10), 4363–4367.
16. Edwards, J. G. (2014). TRPV1 in the central nervous system: synaptic plasticity, function, and pharmacological implications. Progress in Drug Research, 68, 77–104.
17. Edwards, J. G., Gibson, H. E., Jensen, T., Nugent, F., Walther, C., Blickenstaff, J., & Kauer, J. A. (2010). A novel non-CB1/TRPV1 endocannabinoid-mediated mechanism depresses excitatory synapses on hippocampal CA1 interneurons. Hippocampus 22(2)209–221, doi: 10.1002/hipo.20884.
18. Edwards, J. G., Gibson, H. E., Jensen, T., Nugent, F., Walther, C., Blickenstaff, J., & Kauer, J. A. (2012). A novel non-CB1/TRPV1 endocannabinoid-mediated mechanism depresses excitatory synapses on hippocampal CA1 interneurons. Hippocampus, 22(2), 209–221.
19. Gambi, F., De Berardis, D., Sepede, G., Quartesan, R., Calcagni, E., Salerno, R. M., … Ferro, F. M. (2005). Cannabinoid receptors and their relationships with neuropsychiatric disorders. International Journal of Immunopathology and Pharmacology, 18(1), 15–19.
20. Geppert, M., Goda, Y., Stevens, C. F., & Sudhof, T. C. (1997). The small GTP-binding protein Rab3A regulates a late step in synaptic vesicle fusion. Nature, 387(6635), 810–814.
21. Gerdeman, G. L., & Lovinger, D. M. (2003). Emerging roles for endocannabinoids in long-term synaptic plasticity. British Journal of Pharmacology, 140(5), 781–789.
22. Gibson, H. E., Edwards, J. G., Page, R. S., Van Hook, M. J., & Kauer, J. A. (2008). TRPV1 Channels Mediate Long-Term Depression at Synapses on Hippocampal Interneurons. Neuron, 57(5), 746–759.
23. Godlewski, G., Offertaler, L., Wagner, J. A., & Kunos, G. (2009). Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins and Other Lipid Mediators, 89(3–4), 105–111.
24. Guy, A. T., Nagatsuka, Y., Ooashi, N., Inoue, M., Nakata, A., Greimel, P., … Ohta, K. (2015). Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord. Science, 349(6251), 974–977.
25. Hajos, N., & Freund, T. F. (2002). Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chemistry and Physics of Lipids, 121(1–2), 73–82.
26. Hartley, M., Taylor, N., & Taylor, J. (2005). Subfield variations in hippocampal processing-components of a spatial navigation system. Neural Networks, 18(5–6), 611–619.
27. Henstridge, C. M., Balenga, N. A. B., Ford, L. A., Ross, R. A., Waldhoer, M., & Irving, A. J. (2009). The GPR55 ligand L-{alpha}-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB Journal, 23(1), 183–193.
28. Henstridge, C. M., Balenga, N. A. B., Schröder, R., Kargl, J. K., Platzer, W., Martini, L., … Kostenis, E. and others. (2010). GPR55 ligands promote receptor coupling to multiple signalling pathways. British Journal of Pharmacology, 160(3), 604–614.
29. Kallendrusch, S., Kremzow, S., Nowicki, M., Grabiec, U., Winkelmann, R., Benz, A., … Koch, M. (2013). The G protein-coupled receptor 55 ligand l-alpha-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion. Glia, 61(11), 1822–1831.
30. Lauckner, J. E., Jensen, J. B., Chen, H. Y., Lu, H. C., Hille, B., & Mackie, K. (2008). GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proceedings of National Academy of Sciences U S A, 105(7), 2699–2704.
31. Malenka, R. C., & Bear, M. F. (2004). LTP and LTD: an embarrassment of riches. Neuron, 44(1), 5–21.
32. Malleret, G., Alarcon, J. M., Martel, G., Takizawa, S., Vronskaya, S., Yin, D., … Shumyatsky, G. P. (2010). Bidirectional regulation of hippocampal long-term synaptic plasticity and its influence on opposing forms of memory. Journal of Neuroscience, 30(10), 3813–3825.
33. Marichal-Cancino, B. A., Sanchez-Fuentes, A., Mendez-Diaz, M., Ruiz-Contreras, A. E., & Prospero-Garcia, O. (2016). Blockade of GPR55 in the dorsolateral striatum impairs performance of rats in a T-maze paradigm. Behavioral Pharmacology, 27(4), 393–396.
34. Meadows, A., Lee, J. H., Wu, C. S., Wei, Q., Pradhan, G., Yafi, M., … Sun, Y. (2016). Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity. International Journal of Obesity (London), 40(3), 417–424.
35. Merrill, C. B., McNeil, M., Williamson, R. C., Poole, B. R., Nelson, B., Sudweeks, S., & Edwards, J. G. (2012). Identification of mRNA for endocannabinoid biosynthetic enzymes within hippocampal pyramidal cells and CA1 stratum radiatum interneuron subtypes using quantitative real-time polymerase chain reaction. Neuroscience, 218, 89–99.
36. Nemeth, B., Ledent, C., Freund, T. F., & Hajos, N. (2008). CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212–2. Neuropharmacology, 54(1), 51–57.
37. Nicholls, R. E., Alarcon, J. M., Malleret, G., Carroll, R. C., Grody, M., Vronskaya, S., & Kandel, E. R. (2008). Transgenic mice lacking NMDAR-dependent LTD exhibit deficits in behavioral flexibility. Neuron, 58(1), 104–117.
38. Oka, S., Nakajima, K., Yamashita, A., Kishimoto, S., & Sugiura, T. (2007). Identification of GPR55 as a lysophosphatidylinositol receptor. Biochemical and Biophysical Research Communications, 362(4), 928–934.
39. Oka, S., Toshida, T., Maruyama, K., Nakajima, K., Yamashita, A., & Sugiura, T. (2009). 2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55. Journal of Biochemistry, 145(1), 13–20.
40. Pik, J. R., & Thompson, W. (1978). Subcellular distribution of lysophosphatidylinositol and lysophosphatidylcholine acyltransferases in rat brain. Canadian Journal of Biochemistry, 56(8), 765–768.
41. Pineiro, R., & Falasca, M. (2012). Lysophosphatidylinositol signalling: new wine from an old bottle. Biochimica Biophysics Acta, 1821(4), 694–705.
42. Rahimi, A., Hajizadeh Moghaddam, A., & Roohbakhsh, A. (2015). Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats. Fundam Clin Pharmacol, 29(2), 185–190.
43. Rojo, M. L., Rodriguez-Gaztelumendi, A., & Fowler, C. J. (2012). Lysophosphatidylinositol stimulates S-35 GTP gamma S binding in the rat prefrontal cortex and hippocampus. Neurochemical Research, 37(5), 1037–1042.
44. Rouach, N., & Nicoll, R. A. (2003). Endocannabinoids contribute to short-term but not long-term mGluR-induced depression in the hippocampus. European Journal of Neuroscience, 18(4), 1017–1020.
45. Ruban, E. L., Ferro, R., Arifin, S. A., & Falasca, M. (2014). Lysophosphatidylinositol: a novel link between ABC transporters and G-protein-coupled receptors. Biochemical Society Transactions, 42(5), 1372–1377.
46. Ryberg, E., Larsson, N., Sjogren, S., Hjorth, S., Hermansson, N. O., Leonova, J., … Greasley, P. J. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal Pharmacology, 152(7), 1092–1101.
47. Sawzdargo, M., Nguyen, T., Lee, D. K., Lynch, K. R., Cheng, R., Heng, H. H. Q., … O'dowd, B. F. (1999). Identification and cloning of three novel human G protein-coupled receptor genes GPR52, [Psi]GPR53 and GPR55: GPR55 is extensively expressed in human brain. Molecular Brain Research, 64(2), 193–198.
48. Scoville, W. B., & Milner, B. (2000). Loss of recent memory after bilateral hippocampal lesions. J Neuropsychiatry Clinical Neurosciences, 12(1), 103–a-113.
49. Serrano, A., Rivera, P., Pavon, F. J., Decara, J., Suarez, J., Rodriguez de Fonseca, F., & Parsons, L. H. (2012). Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala. Alcoholism Clinical and Experimental Research, 36(6), 984–994.
50. Sharir, H., & Abood, M. E. (2010). Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacology & Therapeutics, 126(3), 301–313.
51. Squire, L. R. (1992). Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychological Reviews, 99(2), 195–231.
52. Staton, P. C., Hatcher, J. P., Walker, D. J., Morrison, A. D., Shapland, E. M., Hughes, J. P., … Billinton, A. (2008). The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain, 139(1), 225–236.
53. Sun, M., Thomas, M. J., Herder, R., Bofenkamp, M. L., Selleck, S. B., & O'connor, M. B. (2007). Presynaptic Contributions of Chordin to Hippocampal Plasticity and Spatial Learning. Journal of Neuroscience, 27(29), 7740–7750.
54. Sylantyev, S., Jensen, T. P., Ross, R. A., & Rusakov, D. A. (2013). Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses. Proceedings of the National Academy of Sciences, 110(13), 5193–5198.
55. Whyte, L. S., Ryberg, E., Sims, N. A., Ridge, S. A., Mackie, K., Greasley, P. J., … Rogers, M. J. (2009). The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proceedings of the National Academy of Sciences U S A, 106(38), 16511–16516.
56. Wu, C. S., Chen, H., Sun, H., Zhu, J., Jew, C. P., Wager-Miller, J., … Mackie, K. (2013). GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination. PLoS One, 8(4), e60314.
57. Yang, H., Zhou, J., & Lehmann, C. (2016). GPR55 - a putative “type 3” cannabinoid receptor in inflammation. Journal of Basic Clinical and Physiological Pharmacology, 27(3), 297–302